In vitro antimicrobial synergy testing of coagulase-negative staphylococci isolated from prosthetic joint infections using Etest and with a focus on rifampicin and linezolid

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 5, 2010, Pages 591-595

  Hellmark, B ^a   Unemo, M ^a   Nilsdotter Augustinsson, A ^b   Soderquist B ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DRUG ADDITIVE; FUSIDIC ACID; LINEZOLID; RIFAMPICIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EPSILOMETER TEST; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFECTIOUS ARTHRITIS; LONG TERM CARE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; STAPHYLOCOCCUS EPIDERMIDIS;

ACETAMIDES; ANTI-INFECTIVE AGENTS; COAGULASE; DRUG SYNERGISM; HUMANS; JOINT PROSTHESIS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; PROSTHESIS-RELATED INFECTIONS; REPRODUCIBILITY OF RESULTS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 77952092699     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-0902-6     Document Type: Article

References (21)

1. W Zimmerli A Trampuz PE Ochsner 2004 Prosthetic-joint infections N Engl J Med 351 16 1645 1654 10.1056/NEJMra040181 1:CAS:528:DC%2BD2cXos1Whtbo%3D 15483283 (Pubitemid 39350425)
2. S Esposito S Leone 2008 Prosthetic joint infections: microbiology, diagnosis, management and prevention Int J Antimicrob Agents 32 4 287 293 10.1016/j.ijantimicag.2008.03.010 1:CAS:528:DC%2BD1cXhtVyjurvP 18617373
3. DM Zavasky MA Sande 1998 Reconsideration of rifampin: A unique drug for a unique infection JAMA 279 19 1575 1577 10.1001/jama.279.19.1575 1:STN:280:DyaK1c3ms12nsA%3D%3D 9605905 (Pubitemid 28233016)
4. DN Collins JM McKenzie 1991 Infections at the site of a hip implant. Successful and unsuccessful management Clin Orthop Relat Res 269 9 15 1864062
5. CE Marculescu EF Berbari AD Hanssen JM Steckelberg SW Harmsen JN Mandrekar DR Osmon 2006 Outcome of prosthetic joint infections treated with debridement and retention of components Clin Infect Dis 42 4 471 478 10.1086/499234 1:STN:280:DC%2BD28%2Fjt1yqtA%3D%3D 16421790 (Pubitemid 43202518)
6. W Zimmerli AF Widmer M Blatter R Frei PE Ochsner 1998 Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial. Foreign-Body Infection (FBI) Study Group JAMA 279 19 1537 1541 10.1001/jama.279.19.1537 1:CAS:528:DyaK1cXjs1ygurk%3D 9605897 (Pubitemid 28233008)
7. A Trampuz DR Osmon AD Hanssen JM Steckelberg R Patel 2003 Molecular and antibiofilm approaches to prosthetic joint infection Clin Orthop Relat Res 414 69 88 10.1097/01.blo.0000087324.60612.93 12966280 (Pubitemid 37102138)
8. S Schwank Z Rajacic W Zimmerli J Blaser 1998 Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics Antimicrob Agents Chemother 42 4 895 898 1:CAS:528:DyaK1cXisFGmtrk%3D 9559803
9. E Svensson H Hanberger LE Nilsson 1997 Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells Antimicrob Agents Chemother 41 1 107 111 1:CAS:528: DyaK2sXhtlyqsA%3D%3D 8980764
10. AF Widmer R Frei Z Rajacic W Zimmerli 1990 Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections J Infect Dis 162 1 96 102 1:CAS:528:DyaK3cXlsVyktLw%3D 2355207
11. JE Berdal I Skråmm P Mowinckel P Gulbrandsen JV Bjørnholt 2005 Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections Clin Microbiol Infect 11 10 843 845 10.1111/j.1469-0691.2005.01230.x 1:CAS:528:DC%2BD2MXhtFeqtrfF 16153261 (Pubitemid 41341720)
12. A Soriano S García G Bori M Almela X Gallart F Macule J Sierra JA Martínez S Suso J Mensa 2006 Treatment of acute post-surgical infection of joint arthroplasty Clin Microbiol Infect 12 9 930 933 10.1111/j.1469-0691. 2006.01463.x 1:STN:280:DC%2BD28vlvV2hsQ%3D%3D 16882303 (Pubitemid 44151298)
13. A Soriano J Gómez L Gómez JR Azanza R Pérez F Romero M Pons F Bella M Velasco J Mensa 2007 Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections Eur J Clin Microbiol Infect Dis 26 5 353 356 10.1007/s10096-007-0289-1 1:STN:280: DC%2BD2s3ntFOmug%3D%3D 17410386 (Pubitemid 46716796)
14. E Senneville L Legout M Valette Y Yazdanpanah E Beltrand M Caillaux H Migaud Y Mouton 2006 Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: A retrospective study Clin Ther 28 8 1155 1163 10.1016/j.clinthera.2006.08.001 1:CAS:528:DC%2BD28XhtVGmsrnF 16982292 (Pubitemid 44374746)
15. G Manno E Ugolotti ML Belli ML Fenu L Romano M Cruciani 2003 Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis Eur J Clin Microbiol Infect Dis 22 1 28 34 1:CAS:528:DC%2BD3sXhtV2kuro%3D 12582741
16. GA Pankey DS Ashcraft 2005 In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa Antimicrob Agents Chemother 49 7 2959 2964 10.1128/AAC.49.7.2959-2964.2005 1:CAS:528:DC%2BD2MXlvFSlsLc%3D 15980375 (Pubitemid 40917617)
17. BT Tsuji MJ Rybak 2006 Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin Diagn Microbiol Infect Dis 54 1 73 77 10.1016/j.diagmicrobio.2005.08.014 1:CAS:528:DC%2BD2MXhtlCrsL7N 16368477 (Pubitemid 41815191)
18. N Rao BH Ziran MM Wagener ER Santa VL Yu 2004 Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections Clin Infect Dis 38 8 1058 1064 10.1086/382356 1:CAS:528:DC%2BD2cXkt12jtr8%3D 15095207 (Pubitemid 38951248)
19. C Jacqueline J Caillon V Le Mabecque AF Miegeville PY Donnio D Bugnon G Potel 2003 In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods J Antimicrob Chemother 51 4 857 864 10.1093/jac/dkg160 1:CAS:528:DC%2BD3sXisleks7w%3D 12654769 (Pubitemid 36503419)
20. CR Bonapace RL White LV Friedrich JA Bosso 2000 Evaluation of antibiotic synergy against Acinetobacter baumannii: A comparison with Etest, time-kill, and checkerboard methods Diagn Microbiol Infect Dis 38 1 43 50 10.1016/S0732- 8893(00)00163-2 1:CAS:528:DC%2BD3cXntF2itLc%3D 11025183
21. RE Lewis DJ Diekema SA Messer MA Pfaller ME Klepser 2002 Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species J Antimicrob Chemother 49 2 345 351 10.1093/jac/49.2.345 1:CAS:528: DC%2BD38XhsFCgs74%3D 11815578